• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺髓样癌的生长抑素受体闪烁扫描术

Somatostatin receptor scintigraphy in medullary thyroid carcinoma.

作者信息

Tisell L E, Ahlman H, Wängberg B, Hansson G, Mölne J, Nilsson O, Lindstedt G, Fjälling M, Forssell-Aronsson E

机构信息

Department of Surgery, Sahlgrenska University Hospital, Göteborg, Sweden.

出版信息

Br J Surg. 1997 Apr;84(4):543-7.

PMID:9112914
Abstract

BACKGROUND

111In-radiolabelled (DTPA-D-Phe1)-octreotide scintigraphy can be used to localize neuroendocrine tumours expressing somatostatin receptors (SSTRs). The aim of this paper was to analyse the importance of tumour volume and growth for the visualization by SSTR scintigraphy of metastases from medullary thyroid carcinoma (MTC).

METHODS

Serum calcitonin concentrations were used to estimate volume and growth rate of MTC. Twenty-two patients who had persistent hypercalcitoninaemia after total thyroidectomy for MTC, indicating the presence of metastases, were studied.

RESULTS

SSTR scintigraphy visualized 15 tumours in 11 patients. Patients with scintigraphically visualized tumours had higher serum calcitonin and carcinoembryonic antigen concentrations and larger tumours, and the serum calcitonin concentration increased more rapidly with time. Tumour-associated symptoms and death from MTC occurred only in patients with scintigraphically visualized tumours.

CONCLUSION

Scintigraphically visualized tumours grow more rapidly and are more aggressive than nonvisualized lesions. SSTR scintigraphy can be helpful in the planning of palliative surgery for MTC and for diagnosing distant metastases, but cannot localize microscopic metastases.

摘要

背景

铟-111标记的(二乙烯三胺五乙酸-D-苯丙氨酸1)-奥曲肽闪烁扫描可用于定位表达生长抑素受体(SSTRs)的神经内分泌肿瘤。本文旨在分析肿瘤体积和生长对甲状腺髓样癌(MTC)转移灶SSTR闪烁扫描可视化的重要性。

方法

血清降钙素浓度用于评估MTC的体积和生长速率。研究了22例因MTC行甲状腺全切除术后仍存在高降钙素血症(提示存在转移)的患者。

结果

SSTR闪烁扫描在11例患者中发现了15个肿瘤。闪烁扫描发现肿瘤的患者血清降钙素和癌胚抗原浓度更高,肿瘤更大,且血清降钙素浓度随时间升高更快。MTC相关症状和死亡仅发生在闪烁扫描发现肿瘤的患者中。

结论

闪烁扫描发现的肿瘤比未发现的病灶生长更快、侵袭性更强。SSTR闪烁扫描有助于MTC姑息手术的规划和远处转移的诊断,但不能定位微小转移灶。

相似文献

1
Somatostatin receptor scintigraphy in medullary thyroid carcinoma.甲状腺髓样癌的生长抑素受体闪烁扫描术
Br J Surg. 1997 Apr;84(4):543-7.
2
The therapeutic value of SST-A octreotide alone or with adjuvant treatment in patients with advanced medullary thyroid carcinoma and positive (111)In-octreotide scan.生长抑素类似物奥曲肽单独或联合辅助治疗对晚期甲状腺髓样癌且(111)铟-奥曲肽扫描阳性患者的治疗价值。
Hell J Nucl Med. 2005 Jan-Apr;8(1):43-7.
3
In vivo somatostatin receptor imaging in medullary thyroid carcinoma.甲状腺髓样癌的体内生长抑素受体显像
J Clin Endocrinol Metab. 1993 Jun;76(6):1413-7. doi: 10.1210/jcem.76.6.8501144.
4
[Somatostatin receptor scintigraphy in medullary thyroid carcinomas, GEP and carcinoid tumors].[生长抑素受体闪烁扫描术在甲状腺髓样癌、胃肠胰神经内分泌肿瘤及类癌肿瘤中的应用]
Nuklearmedizin. 1995 Feb;34(1):1-7.
5
111In-pentetreotide scintigraphy in the post-thyroidectomy follow-up of patients with medullary thyroid carcinoma.111铟-喷替酸奥曲肽闪烁扫描术在甲状腺髓样癌患者甲状腺切除术后随访中的应用
Q J Nucl Med. 1995 Dec;39(4 Suppl 1):131-3.
6
Use of somatostatin analogue scintigraphy in the localization of recurrent medullary thyroid carcinoma.生长抑素类似物闪烁扫描术在复发性甲状腺髓样癌定位中的应用。
Eur J Nucl Med. 1998 Nov;25(11):1482-8. doi: 10.1007/s002590050325.
7
Indium-111-DTPA-D-Phe-1-octreotide and technetium-99m-(V)-dimercaptosuccinic acid scanning in the preoperative staging of medullary thyroid carcinoma.铟-111-二乙三胺五乙酸-D-苯丙氨酸-1-奥曲肽和锝-99m-(V)-二巯基丁二酸扫描在甲状腺髓样癌术前分期中的应用
J Nucl Med. 1998 Nov;39(11):1907-9.
8
The relevance of somatostatin receptors in thyroid neoplasia.生长抑素受体在甲状腺肿瘤中的相关性。
Yale J Biol Med. 1997 Sep-Dec;70(5-6):523-33.
9
111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors.111铟-二乙三胺五乙酸-D-苯丙氨酸1-奥曲肽在甲状腺肿瘤中的结合及生长抑素受体亚型
J Nucl Med. 2000 Apr;41(4):636-42.
10
Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging.[111In]二巯基丁二酸-奥曲肽闪烁扫描法(Octreoscan)对神经内分泌肿瘤的定位:与CT和MRI成像的对比研究
QJM. 1998 Apr;91(4):295-301. doi: 10.1093/qjmed/91.4.295.

引用本文的文献

1
Routine preoperative (111)In-octreotide scintigraphy in patients with medullary thyroid cancer.对有髓样甲状腺癌的患者进行常规术前(111)喷曲肽闪烁扫描。
Langenbecks Arch Surg. 2013 Aug;398(6):875-80. doi: 10.1007/s00423-013-1086-1. Epub 2013 May 19.
2
Somatostatin receptor SPECT.生长抑素受体 SPECT。
Eur J Nucl Med Mol Imaging. 2012 Feb;39 Suppl 1:S41-51. doi: 10.1007/s00259-011-2019-2.
3
(111)In-octreotide scintigraphy for identification of metastatic medullary thyroid carcinoma in children and adolescents.奥曲肽闪烁显像术在儿童和青少年有转移的髓样甲状腺癌的诊断中的应用。
J Clin Endocrinol Metab. 2012 Feb;97(2):E207-12. doi: 10.1210/jc.2011-2766. Epub 2011 Dec 7.
4
Chronic bronchitis mimicking metastases from thyroid medullary carcinoma demonstrated by indium-111 pentetreotide scintigraphy.铟-111五肽胃泌素闪烁扫描显示类似甲状腺髓样癌转移的慢性支气管炎
Cancer Imaging. 2008 Apr 24;8(1):118-20. doi: 10.1102/1470-7330.2008.0016.
5
Somatostatin receptors and their interest in diagnostic pathology.生长抑素受体及其在诊断病理学中的意义。
Endocr Pathol. 2004 Winter;15(4):275-91. doi: 10.1385/ep:15:4:275.
6
The Ki67 index a prognostic marker in medullary thyroid carcinoma.Ki67指数是甲状腺髓样癌的一种预后标志物。
Br J Cancer. 2003 Dec 1;89(11):2093-7. doi: 10.1038/sj.bjc.6601453.
7
Octreoscan radioreceptor imaging.奥曲肽扫描放射性受体显像
Endocrine. 2003 Apr;20(3):307-11. doi: 10.1385/ENDO:20:3:307.
8
Expression of somatostatin receptors in oncocytic (Hürthle cell) neoplasia of the thyroid.生长抑素受体在甲状腺嗜酸细胞(许特莱细胞)肿瘤中的表达
Br J Cancer. 1999 Mar;79(9-10):1579-82. doi: 10.1038/sj.bjc.6690251.
9
The relevance of somatostatin receptors in thyroid neoplasia.生长抑素受体在甲状腺肿瘤中的相关性。
Yale J Biol Med. 1997 Sep-Dec;70(5-6):523-33.
10
Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours.类癌肿瘤患者生长抑素受体亚型表达、奥曲肽闪烁扫描结果及对奥曲肽治疗反应的比较研究
Br J Cancer. 1998 Feb;77(4):632-7. doi: 10.1038/bjc.1998.101.